Na, Rong http://orcid.org/0000-0001-7470-5108
Wei, Jun
Sample, Chris J. http://orcid.org/0000-0003-3158-622X
Gielzak, Marta
Choi, Sodam
Cooney, Kathleen A.
Rabizadeh, Daniel
Walsh, Patrick C.
Zheng, Lilly S.
Xu, Jianfeng http://orcid.org/0000-0002-1343-8752
Isaacs, William B. http://orcid.org/0000-0001-6599-6775
Funding for this research was provided by:
U.S. Department of Defense (W81XWH-16-1-0766, W81XWH-16-1-0765, W81XWH-16-1-0764)
Patrick C Walsh Hereditary Prostate Cancer program
Article History
Received: 26 March 2021
Revised: 21 October 2021
Accepted: 29 October 2021
First Online: 19 November 2021
Competing interests
: KAC and WBI are coinventors on a patent (no. 9593380; Inst.) related to the discovery of HOXB13 as a prostate cancer susceptibility gene.
: The study was approved by the Institutional Review Boards at Johns Hopkins University. The study was performed in accordance with the Declaration of Helsinki.
: All the authors have reviewed and approved the current version of the manuscript.